Page last updated: 2024-12-08
bisdequalinium
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
bisdequalinium: Salvizol is N(1),N(1')-decamethylene-N(4),N(4')-decamethylene-bis-4-aminoquinaldinium-diacetate 0.5% in propylene glycol, pH 6.6; RN given refers to parent cpd; structure; BIS-DEQUALINIUM & SALVISOL were ENs to DEQUALINIUM 1984-93 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 159796 |
CHEMBL ID | 2110751 |
CHEBI ID | 135886 |
MeSH ID | M0065197 |
Synonyms (18)
Synonym |
---|
n(sup 1),n(sup 1)'-dekamethylen-n(sup 4),n(sup 4)'-dekamethylen-bis-4-amino-chinaldinium |
bisdequalinium |
r 199 |
n,n'-decamethylene-n(4),n(4')-decamthylenebis(4-aminoquinaldinium chloride) |
quinaldinium, 1,1'-decamethylene-4,4'-(decamethylenediimino)di-, dibromide |
5,34:16,21-diethenodibenzo(b,r)(1,5,16,20)tetraazacyclotriaconti-5,16-diium, 6,7,8,9,10,11,12,13,14,15,22,23,24,25,26,27,28,29,30,31,32,33-docosahydro-36,38-dimethyl-, dibromide |
CHEBI:135886 |
16776-40-2 |
n848p5o593 , |
unii-n848p5o593 |
bisdequalinium cation |
bisdequalinium ion |
5,34:18,23-diethenodibenzo(b,r)(1,5,16,20)tetraazacyclotriacontine-23,34-diium, 6,7,8,9,10,11,12,13,14,15,16,17,24,25,26,27,28,29,30,31,32,33-docosahydro-35,37-dimethyl- |
bisdequalinium [who-dd] |
6,7,8,9,10,11,12,13,14,15,16,17,24,25,26,27,28,29,30,31,32,33-docosahydro-35,37-dimethyl-5,34:18,23-diethenodibenzo(b,r)(1,5,16,20)tetraazacyclotriacontine-23,24-diium |
CHEMBL2110751 |
39,42-dimethyl-20,31-diaza-1,12-diazoniapentacyclo[30.6.2.212,19.013,18.033,38]dotetraconta-1(39),12(42),13,15,17,19(41),32(40),33,35,37-decaene |
Q27284693 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (26)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 23 (88.46) | 18.7374 |
1990's | 2 (7.69) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (3.85) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 26 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |